US Patent Issued to Regeneron Pharmaceuticals on Nov. 1 for "HSD17B13 variants and uses thereof" (New York, California, Connecticut, Maryland, Massachusetts, New Jersey Inventors)

Press/Media

Period	2 Nov 2022

Media coverage

Title	US Patent Issued to Regeneron Pharmaceuticals on Nov. 1 for "HSD17B13 variants and uses thereof" (New York, California, Connecticut, Maryland, Massachusetts, New Jersey Inventors)
Media name/outlet	US Fed News
Country/Territory	United States
Date	2/11/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66S7-9WN1-JDKC-R15M-00000-00
Persons	Noura Abul-Husn